Current News:

• Karolinska Institutet to Test Vical’s Vaxfectin® Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control

• Bioject Reports Second-Quarter 2008 Financial Results (Audio)

• Bioject Reports Second-Quarter 2008 Financial Results

• BIOJECT TO REPORT SECOND QUARTER 2008 FINANCIAL RESULTS

• Bioject Announces Long-Term Agreement With Merial Limited

• Bioject to Be Transferred to the over-the-Counter Bulletin Board

• Biojector®2000 Data Presented in Vical’s Pandemic Influenza DNA Vaccine Human Trial

• Bioject and ImmunoVaccine Technologies Announce Research Collaboration

• Biojector®2000 Technology Put to the Test in CDC Flu Vaccine Study